Mydecine Innovations Group Inc. (FRA:0NF0)
Germany
· Delayed Price · Currency is EUR 0.0972
0.00 (0.00%)
At close: Dec 5, 2025
FRA:0NF0 Revenue
Revenue
n/a
Revenue Growth
n/a
P/S Ratio
n/a
Revenue / Employee
n/a
Employees
n/a
Market Cap
102.35K EUR
Revenue Chart
* This company reports financials in CAD.
Revenue Definition
Revenue, also called sales, is the amount of money a company receives from its business activities, such as sales of products or services. Revenue does not take any expenses into account and is therefore different from profits.
Full DefinitionRelated Stocks
| Company Name | Revenue |
|---|---|
| SAP SE | 36.49B |
| Siemens Aktiengesellschaft | 78.91B |
| Allianz SE | 105.02B |
| Deutsche Telekom AG | 121.02B |
| Siemens Energy AG | 39.08B |
| Münchener Rückversicherungs-Gesellschaft Aktiengesellschaft in München | 62.10B |
| Rheinmetall AG | 11.00B |
| Deutsche Bank Aktiengesellschaft | 29.86B |
Mydecine Innovations Group News
- 6 weeks ago - CSE Bulletin: Consolidation - Mydecine Innovations Group Inc. (MYCO) - Newsfile Corp
- 7 weeks ago - Mydecine Innovations Group Closes Debt Settlements - TheNewswire
- 2 months ago - Mydecine Innovations Group Announces Results Of Shareholder Meeting And Provides Corporate Update - TheNewswire
- 5 months ago - Mydecine Innovations Group Provides Update On Annual Financial Statements - TheNewswire
- 6 months ago - Mydecine Innovations Group Provides Update on Annual Financial Statements - TheNewswire
- 7 months ago - Mydecine Innovations Group Announces Late Filing Of Annual Financial Statements And Management Cease Trade Order - TheNewswire
- 9 months ago - Mydecine Innovations Group Announces Changes To Board And Management - TheNewswire
- 1 year ago - Mydecine Innovations Group Receives Two Notice of Allowances from USPTO for its MYCO-005 and MYCO-006 Family of Compounds - GlobeNewsWire